Pfizer Asks FDA Expand Use Of COVID-19 To Children Ages 12-15
CBS 2 New York
Pfizer is asking the FDA to expand the use of its COVID-19 vaccine to include children ages 12 to 15.
Pfizer is asking the FDA to expand the use of its COVID-19 vaccine to include children ages 12 to 15.
Based on a late-stage trial, Pfizer says its vaccine is more than 91% effective against COVID at least six months after the second..
Pfizer has completed its findings in adolescents 12 to 15 years of age calling its vaccine 100 percent effective against COVID-19...